CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP, Chief Medical Officer acquired 4,008 shares (option exercise)
- 4 Option exercise EVP & CHRO acquired 3,922 shares (option exercise)
- 4 Option exercise EVP, Gbl Ops & SC & CTO acquired 5,242 shares (option exercise)
- 4 Option exercise EVP & General Counsel acquired 3,518 shares (option exercise)
- 4 Option exercise EVP and CIO acquired 1,881 shares (option exercise)
- 4 Option exercise EVP & Chief Financial Officer acquired 4,870 shares (option exercise)
- 4 Option exercise EVP & Chief Scientific Officer acquired 3,776 shares (option exercise)
- 4 Option exercise EVP & President CHCI acquired 9,256 shares (option exercise)
- 4 Open-market buy EVP & Chief Scientific Officer bought 2,490 shares at $27.26 ($67,877)
- 4 Open-market buy EVP & Chief Scientific Officer bought 1,545 shares at $26.44 ($40,850)
- 4/A Open-market buy EVP & Chief Scientific Officer bought 2,040 shares at $29.34 ($59,854)
- 4 Grant or award EVP, Gbl Ops & SC & CTO acquired 11,806 shares (grant or award)
- 4 Grant or award EVP & CHRO acquired 7,291 shares (grant or award)
Page 8 of 41 · 805 filings